DALLAS, TX--(Marketwired - May 5, 2016) - Refocus Group, a pioneer in vision-correcting technology, announced today that it has completed the enrollment of its Phase 3 clinical trial on the ...
DALLAS, April 12, 2018 (GLOBE NEWSWIRE) -- Refocus Group, a pioneer in vision-correcting technology, announced today that it has expanded its manufacturing and assembly capacity, and is strategically ...
Optometrists have an expanding array of options to offer today’s presbyopes who seek high-quality solutions to their near-vision needs. Unlike previous generations, current presbyopes rely heavily on ...
DALLAS, TX--(Marketwired - May 4, 2017) - Refocus Group, a pioneer in vision-correcting technology, announced today that it has successfully completed its 12-month follow-up on 360 patients in its ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Phase 3 safety and efficacy studies are ...
DALLAS, TX--(Marketwired - May 5, 2016) - Refocus Group, a pioneer in vision-correcting technology, announced today that it has completed the enrollment of its Phase 3 clinical trial on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results